uPA, uPAR and TGFβ1 expression during early and late post myocardial infarction period in rat myocardium

In Vivo

Volumn 24, Issue 5, 2010, Pages 647-652

  Stavropoulou, Anastasia ^a   Philippou, Anastassios ^a   Halapas, Antonios ^a   Sourla, Antigone ^b   Pissimissis, Nikolaos ^a   Koutsilieris, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Diagnostic and Therapeutic Medical Center   (Greece)

Author keywords

Myocardial infarction; UPA; UPAR

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE; UROKINASE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY LIGATION; EXPERIMENTAL MODEL; HEART INFARCTION; HEART MUSCLE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

EID: 78649261971     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Fedak PW, Verma S, Weisel RD, Skrtic M and Li RK: Cardiac remodeling and failure: from molecules to man (Part III). Cardiovasc Pathol 14: 109-119, 2005. (Pubitemid 40725586)
2. Fedak PW, Verma S, Weisel RD and Li RK: Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc Pathol 14: 49-60, 2005. (Pubitemid 40381300)
3. Fedak PW, Verma S, Weisel RD and Li RK: Cardiac remodeling and failure: from molecules to man (Part I). Cardiovasc Pathol 14: 1-11, 2005. (Pubitemid 40248426)
4. Cleutjens JP, Blankesteijn WM, Daemen MJ and Smits JF: The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res 44: 232-241, 1999.
5. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV and Weber KT: Regulation of collagen degradation in the rat myocardium after infarction? J Mol Cell Cardiol 27: 1281-1292, 1995.
6. Verrecchia F, Chu ML and Mauviel A: Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276: 17058-17062, 2001.
7. Godar S, Horejsi V, Weidle UH, Binder BR, Hansmann C and Stockinger H: M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol 29: 1004-1013, 1999.
8. Leksa V, Godar S, Cebecauer M, Hilgert I, Breuss J, Weidle UH, Horejsi V, Binder BR and Stockinger H: The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration. J Biol Chem 277: 40575-40582, 2002.
9. Leksa V, Godar S, Schiller HB, Fuertbauer E, Muhammad A, Slezakova K, Horejsi V, Steinlein P, Weidle UH, Binder BR and Stockinger H: TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen. J Cell Sci 118: 4577-4586, 2005.
10. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ and Carmeliet P: Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5: 1135-1142, 1999.
11. Irigoyen JP, Munoz-Canoves P, Montera L, Koziczak M and Nagamine Y: The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56: 104-132, 1999.
12. Stepanova VV and Tkachuk VA: Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) 67: 109-118, 2002.
13. Rifkin DB, Mazzieri R, Munger JS, Noguera I and Sung J: Proteolytic control of growth factor availability. APMIS 107: 80-85, 1999.
14. Bogdanos J, Karamanolakis D, Tenta R, Tsintavis A, Milathianakis C, Mitsiades C and Koutsilieris M: Endocrine/paracrine/autocrine survival factor activity of bone microenvironment participates in the development of androgen ablation and chemotherapy refractoriness of prostate cancer metastasis in skeleton. Endocr Relat Cancer 10: 279-289, 2003.
15. Koutsilieris M, Mitsiades C and Sourla A: Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: development of anti-survival factor therapy for hormone-refractory prostate cancer. Mol Med 6: 251-267, 2000.
16. Hyytiainen M, Penttinen C and Keski-Oja J: Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41: 233-264, 2004.
17. Robertson TA, Maley MA, Grounds MD and Papadimitriou JM: The role of macrophages in skeletal muscle regeneration with particular reference to Chemotaxis. Exp Cell Res 207: 321-331, 1993.
18. Border WA and Noble NA: Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
19. Stavropoulou A, Halapas A, Sourla A, Philippou A, Papageorgiou E, Papalois A and Koutsilieris M: IGF-1 expression in infarcted myocardium and MGF-E peptide actions in rat cardiomyocytes in vitro. Mol Med 15: 127-135, 2009.
20. Bickel CS, Slade JM, Haddad F, Adams GR and Dudley GA: Acute molecular responses of skeletal muscle to resistance exercise in able-bodied and spinal cord-injured subjects. J Appl Physiol 94: 2255-2262, 2003.
21. Kim JS, Cross JM and Bamman MM: Impact of resistance loading on myostatin expression and cell cycle regulation in young and older men and women. Am J Physiol Endocrinol Metab 288: E1110-1119, 2005.
22. McKee PA, Castelli WP, McNamara PM and Kannel WB: The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441-1446, 1971.
23. Lloyd-Jones DM, Larson MG, Leip EP, Beiser A, D'Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ and Levy D: Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106: 3068-3072, 2002.
24. Ju H, Zhao S, Tappia PS, Panagia V and Dixon IM: Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. Circulation 97: 892-899, 1998.
25. Sutton MG and Sharpe N: Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation 101: 2981-2988, 2000.
26. Chen D, Assad-Kottner C, Orrego C and Torre-Amione G: Cytokines and acute heart failure. Crit Care Med 36: S9-16, 2008.
27. Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 24: 111-119, 1998.
28. Massague J and Chen YG: Controlling TGF-beta signaling. Genes Dev 14: 627-644, 2000.
29. Verrecchia F and Mauviel A: Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118: 211-215, 2002.
30. Danielpour D and Song K: Cross-talk between IGF-I and TGF-beta signaling pathways. Cytokine Growth Factor Rev 17: 59-74, 2006.
31. Grainger DJ: Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24: 399-404, 2004.
32. Lefer AM, Tsao P, Aoki N and Palladino MA, Jr.: Mediation of cardioprotection by transforming growth factor-beta. Science 249: 61-64, 1990.
33. Schultz Jel J, Witt SA, Glascock BJ, Nieman ML, Reiser PJ, Nix SL, Kimball TR and Doetschman T: TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest 109: 787-796, 2002.
34. Ragno P, Montuori N, Vassalli JD and Rossi G: Processing of complex between urokinase and its type-2 inhibitor on the cell surface. A possible regulatory mechanism of urokinase activity. FEBS Lett 323: 279-284, 1993.
35. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F and Collen D: Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17: 439-444, 1997.
36. Suelves M, Lopez-Alemany R, Lluis F, Aniorte G, Serrano E, Parra M, Carmeliet P and Munoz-Canoves P: Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99: 2835-2844, 2002.
37. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, Verdiere-Sahuque M, Fardeau M and Alameddine HS: Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205: 158-170, 1999.
38. Creemers E, Cleutjens J, Smits J, Heymans S, Moons L, Collen D, Daemen M and Carmeliet P: Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. Am J Pathol 156: 1865-1873, 2000.
39. Ng F, Boucher S, Koh S, Sastry KS, Chase L, Lakshmipathy U, Choong C, Yang Z, Vemuri MC, Rao MS and Tanavde V: PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112: 295-307, 2008.
40. Hill M, Wernig A and Goldspink G: Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 203: 89-99, 2003.
41. Philippou A, Maridaki M, Halapas A and Koutsilieris M: The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo 21: 45-54, 2007. (Pubitemid 46359198)